J&J E-mails Link Research Center, Risperdal

Law360, New York (November 25, 2008, 12:00 AM EST) -- E-mail messages released as part of a lawsuit over Johnson & Johnson's anti-psychotic Risperdal have revealed that the drugmaker worked with a renowned psychiatrist to launch a research center, allegedly for the purpose of marketing the drug for use in children before that use was approved.

The internal e-mails — from J&J subsidiary Janssen Pharmaceutica employees — concern Massachusetts General Hospital physician Joseph Biederman, who has come under fire recently for his drug company ties. The 2002 e-mails reveal the psychiatrist's interest in creating a “Janssen/...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.